Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 553,439 | 112,637 | 41,958 | 56,718 | 25,031 |
| Marketable Securities | 51,987 | 27,798 | 26,943 | 27,999 | 19,854 |
| Receivables | N/A | N/A | N/A | 108 | 84 |
| Other current assets | 1,083 | 611 | 439 | 437 | 216 |
| TOTAL | $611,740 | $149,151 | $79,031 | $93,318 | $50,864 |
| Non-Current Assets | |||||
| PPE Net | 481 | 282 | 251 | 248 | 328 |
| Intangibles | 799 | 799 | 799 | 799 | 799 |
| Other Non-Current Assets | 12,622 | 12,782 | 3,535 | 3,016 | 2,790 |
| TOTAL | $13,902 | $13,863 | $4,585 | $4,063 | $3,917 |
| Total Assets | $625,642 | $163,014 | $83,616 | $97,381 | $54,782 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,014 | 30,041 | 36,377 | 25,877 | 15,268 |
| Accrued Expenses | 8,456 | 3,798 | 2,258 | 1,800 | 1,390 |
| Other current liabilities | 18,236 | 48,994 | 219 | N/A | N/A |
| TOTAL | $87,554 | $84,449 | $38,854 | $27,957 | $16,878 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,716 | 28,970 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 152 | 152 |
| Other Non-Current Liabilities | 10,412 | 10,218 | 18,350 | 0 | 0 |
| TOTAL | $18,738 | $39,950 | $20,726 | $2,431 | $2,035 |
| Total Liabilities | $106,292 | $124,399 | $59,580 | $30,388 | $18,914 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 140,586 | 109,401 | 83,871 | 75,580 | 56,909 |
| Common Shares | 141 | 109 | 84 | 73 | 57 |
| Retained earnings | -980,597 | -701,216 | -528,345 | -354,863 | -236,387 |
| Other shareholders' equity | -234 | -234 | -234 | -234 | -234 |
| TOTAL | $519,350 | $38,615 | $24,036 | $66,993 | $35,868 |
| Total Liabilities And Equity | $625,642 | $163,014 | $83,616 | $97,381 | $54,782 |